Infection and Drug Resistance
Overview
Infection and Drug Resistance is a peer-reviewed journal that focuses on the latest research and advancements in the field of infectious diseases and drug resistance. It provides a platform for scientists, clinicians, and researchers to share their findings and insights on the prevention, diagnosis, and treatment of infections, as well as the development of novel drugs and strategies to combat drug resistance. The journal aims to contribute to the global efforts in improving patient outcomes and public health by addressing the challenges posed by infectious diseases and the emergence of resist
Details
Details
Abbr.
Infect Drug Resist
Publisher
Dove Medical Press
Start
2008
End
Continuing
Frequency
Irregular
e-ISSN
1178-6973
Country
New Zealand
Language
English
Metrics
Metrics
h-index / Ranks: 5603
65
SJR / Ranks: 5866
743
CiteScore / Ranks: 4133
5.70
JIF / Ranks: 2352
3.9
Recent Articles
21.
Zhou W, Cheng H, Li M, Zhang R, Li Z, Sun G, et al.
Infect Drug Resist
. 2025 Mar;
18:1149-1159.
PMID: 40027915
Purpose: This study evaluates and compares the eradication rates of Helicobacter pylori (H. pylori) achieved through susceptibility-guided therapy (SGT) based on resistance genotyping and empirical therapy (ET). Patients And Methods:...
22.
Huang M, Wang Y, Lu Y, Qu W, Zou Q, Zhang D, et al.
Infect Drug Resist
. 2025 Mar;
18:1171-1181.
PMID: 40027914
Introduction: Psittacosis pneumonia, as a zoonotic infection, is induced by the pathogen . In the present study, we sought to characterize the clinical manifestations and prognosticate the severity of psittacosis...
23.
Qin W, You T, Guo T, Tian R, Cui X, Wang P
Infect Drug Resist
. 2025 Mar;
18:1111-1123.
PMID: 40027913
Objective: To analyze independent risk factors and the distribution of pathogenic bacteria associated with pulmonary infection (PI) in patients with non-small cell lung cancer (NSCLC); and to explore the utility...
24.
Shao P, Jiang Y, Mei C, Li W, Wang Z, Jiao X, et al.
Infect Drug Resist
. 2025 Mar;
18:1183-1186.
PMID: 40027912
No abstract available.
25.
Chen Z, Shang Y, Wasti B, Ou Y, Gong S, Xiang X, et al.
Infect Drug Resist
. 2025 Feb;
18:1059-1070.
PMID: 40008248
Objective: In the real clinical world, both surgery and medication are used to treat pulmonary aspergillosis (PA), but the prognosis of different treatments is unclear. The purpose of this study...
26.
Wang C, Zhang H, Zhao R, Tsui C, Deng S
Infect Drug Resist
. 2025 Feb;
18:1049-1057.
PMID: 39996143
Background: The prevalence of third-generation cephalosporin-resistant and extended-spectrum beta-lactamases (ESBL) producing poses a significant global public health concern due to their resistance to multiple antibiotics; however, their prevalence and epidemiological...
27.
Chen Y, Chen B, Huang Y, Li X, Wu J, Lin R, et al.
Infect Drug Resist
. 2025 Feb;
18:941-955.
PMID: 39990787
Purpose: This study aimed to describe the population pharmacokinetics (PopPK) of ceftazidime-avibactam (CAZ-AVI) in adult patients, and to develop optimal dosing regimens for both non-critically ill and critically ill patients...
28.
Zhang Y, Chen J, Yang X, Wu Y, Wang Z, Xu Y, et al.
Infect Drug Resist
. 2025 Feb;
18:1035-1048.
PMID: 39990786
Purpose: This study aimed to investigate the epidemiology and dissemination of -positive in urban sewage in Yangzhou, China. Methods: A total of 366 sewage samples were collected from the Yangzhou...
29.
Sun Q, Hao J, Zhou Q, Zeng Y
Infect Drug Resist
. 2025 Feb;
18:957-963.
PMID: 39990785
Background: pneumonia (MPP) is a prevalent disease among children. Typically, macrolides are the first-line treatment for MPP in China. However, the number of cases resistant to macrolides has been rising,...
30.
Yan A, Pan X, Li S, Hu Y, Zhang H, Li D, et al.
Infect Drug Resist
. 2025 Feb;
18:965-977.
PMID: 39990784
Background: Multidrug-resistant Gram-negative bacteria (MRGN) pose a significant threat and require priority attention. Polymyxin B (PMB) retains substantial activity against MRGN and makes it potentially the last resort therapy for...